Topiramate in the treatment of chronic migraine

Cephalalgia

Volumn 23, Issue 8, 2003, Pages 820-824

  Silvestrini, Mauro ^a,b   Bartolini, M ^a   Coccia, M ^a   Baruffaldi, R ^a   Taffi, R ^a   Provinciali, L ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Chronic migraine; Follow up; Topiramate

Indexed keywords

ANALGESIC AGENT; TOPIRAMATE;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG USE; EVALUATION; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; LOW DRUG DOSE; MALE; MIGRAINE; PARESTHESIA; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; TITRIMETRY; TREATMENT OUTCOME;

ADULT; ANALGESICS; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; CONFIDENCE INTERVALS; DOUBLE-BLIND METHOD; FEMALE; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; MULTIVARIATE ANALYSIS; ODDS RATIO;

EID: 0141959059     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2003.00592.x     Document Type: Article

References (25)

1. Welch KMA, Goasdsby PJ. Chronic daily headache: nosology and pathophysiology. Curr Opin Neurol 2002; 15:287-95.
2. Hering R, Gardiner I, Catarci T, Witmarsh T, Steiner T, de Belleroche J. Cellular adaptation in migraineurs with chronic daily headache. Cephalalgia 1993; 13:261-6.
3. Rosenfeld WE. Topiramate: a review of preclinical, pharmacokinetic, and clinical data. Clin Ther 1997; 19:1294-308.
4. Silberstein SD, Lipton RB, Solomon S, Mathew NT. Classification of daily and near daily headaches: field trial of revised of IHS criteria. Neurology 1996; 47:871-5.
5. Guitera V, Munoz P, Castillo J, Pascual J. Transformed migraine: a proposal for the modification of this diagnostic criteria based on recent epidemiological data. Cephalalgia 1999; 19:847-50.
6. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 Suppl. 7:1-96.
7. Lipton RB, Stewart WF, Sawyer J, Edmeads JC. Clinical utility of an instrument assessing migraine disability: the Migraine Disability Assessment (MIDAS) questionnaire. Headache 2001; 41:854-61.
8. White HS, Brown SD, Woodead JH, Skean GA, Wolf HH. Topiramate enhances GABA-mediated chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res 1997; 28:167-79.
9. Kuzniecky R, Hetherington H, Ho S, Pan J, Martin R et al. Topiramate increases cerebral GABA in healthy humans. Neurology 1998; 51:627-9.
10. Edwards KR, Glantz MJ, Button J, Norton JA, Whittaker T, Cross N. The evaluation of topiramate in the management of painful diabetic neuropathy: a double-blind, placebo-controlled study. Neurology 2000; 54 Suppl. 3:A81.
11. Storey JR, Calder CS, Hurt DE, Potter DL. Topiramate in migraine prevention: a double blind placebo controlled study. Headache 2001; 41:968-75.
12. Wheeler SD, Carrazana E. Topiramate-treated cluster headache. Neurology 1999; 53:234-5.
13. Forderreuther S, Mayer M, Straube A. Treatment of cluster headache with topiramate: effects and side-effects in five patients. Cephalalgia 2002; 22:186-9.
14. Guitera V, Munoz P, Castillo J, Pascual J. Quality of life in chronic daily headache. A study in a general population. Neurology 2002; 58:1062-5.
15. Pini LA, Bigarelli M, Vitale G, Sternieri E. Headache associated with chronic use of analgesics: a therapeutic approach. Headache 1996; 36:433-29.
16. Pini LA, Cicero AFG, Sandrini G. Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia 2001; 21:878-83.
17. Welch KMA, Nagesh V, Aurora S, Gelman N. Periaqueductal gray matter disfunction in migraine, cause or the burden of illness? Headache 2001; 41:629-37.
18. Welch KMA, Cao Y, Aurora S, Wiggins G, Vikingstad EM. MRI of the occipital cortex, red nucleous, and substantia nigra during visual aurea of migraine. Neurology 1998; 51:1465-9.
19. Depaulis A, Bandler R, editors. The Midbrain Periaqueductal Gray Matter: Functional, Anatomical and Neurochemical Organization. New York: Plenum Press, 1991.
20. Fields HL, Basbaum AI. Central Nervous system mechanism of pain modulation. In: Wall PD, Melzack R, editors. Textbook of Pain. Edinburgh: Churchill-Livingstone, 1994:243-57.
21. Freitag FG, Diamond S, Diamond ML, Urban GJ. Divalproex in the long-term treatment of chronic daily headache. Headache 2001; 41:271-8.
22. Rothrock JF. Management of chronic daily headache utilizing a uniform treatment pathway. Headache 1999; 39:650-3.
23. Krusz JC, Scott V. Topiramate in the treatment of chronic migraine and other headaches. Headache 1999; 39:363.
24. Storey JR, Calder CS, Potter DL. Potential role of topiramate (TPM) in the treatment of intractable daily headache: a retrospective pilot study. Neurology 1999; 52 Suppl. 2:A211.
25. Young WB, Hopkins MM, Shechter AL, Silberstein SD. Topiramate: a case series study in migraine prophylaxis. Cephalalgia 2002; 22:659-63.